Green Cross Corp (006280) - Financial and Strategic SWOT Analysis Review

Date: June 13, 2017
Pages: 38
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G2FB96F180EEN
Leaflet:

Download PDF Leaflet

Green Cross Corp (006280) - Financial and Strategic SWOT Analysis Review
Green Cross Corp (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Green Cross Corp (Green Cross), a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and antithrombin; vaccines for infectious diseases; prescription drugs for treating cardiovascular, respiratory, central nervous system (CNS), gastrointestinal and immunology diseases, musculoskeletal disorders, genetic disorders, metabolic disorders and hematological disorders; and Over-the-counter (OTC) drugs including anti-inflammatory drugs, anti-allergic products and others. The company focuses its research and development activities at developing pharmaceuticals for difficult to treat diseases, including cancer. Green Cross is headquartered Yongin-si, Gyeonggi-do, South Korea.

Green Cross Corp Key Recent Developments

Apr 29,2017: Green Cross to Build Cell Therapy Manufacturing Facility in China
May 31,2016: Marken And Green Cross LabCell Sign MOU

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Green Cross Corp - Key Facts
Green Cross Corp - Key Employees
Green Cross Corp - Key Employee Biographies
Green Cross Corp - Major Products and Services
Green Cross Corp - History
Green Cross Corp - Company Statement
Green Cross Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Green Cross Corp - Business Description
Green Cross Corp - Corporate Strategy
Green Cross Corp - SWOT Analysis
SWOT Analysis - Overview
Green Cross Corp - Strengths
Green Cross Corp - Weaknesses
Green Cross Corp - Opportunities
Green Cross Corp - Threats
Green Cross Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Green Cross Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Green Cross Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Green Cross Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 29, 2017: Green Cross to Build Cell Therapy Manufacturing Facility in China
May 31, 2016: Marken And Green Cross LabCell Sign MOU

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Green Cross Corp, Key Facts
Green Cross Corp, Key Employees
Green Cross Corp, Key Employee Biographies
Green Cross Corp, Major Products and Services
Green Cross Corp, History
Green Cross Corp, Other Locations
Green Cross Corp, Subsidiaries
Green Cross Corp, Key Competitors
Green Cross Corp, Ratios based on current share price
Green Cross Corp, Annual Ratios
Green Cross Corp, Annual Ratios (Cont.1)
Green Cross Corp, Annual Ratios (Cont.2)
Green Cross Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Green Cross Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Green Cross Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Green Cross Corp, Performance Chart (2012 - 2016)
Green Cross Corp, Ratio Charts
Green Cross Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Green Cross Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Yuhan Corp
ViroMed Co Ltd
Suheung Capsule Co Ltd
Seoul Pharma Co Ltd
Sam Chun Dang Pharm Co Ltd
Kolon Life Science Inc
Jeil Pharmaceutical Co Ltd
Hwail Pharma Co Ltd
Huons Co Ltd
Genexine Inc
EstechPharma Co Ltd
Skip to top


Ask Your Question

Green Cross Corp (006280) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: